Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
posted on
Jun 13, 2023 05:38PM
Just a quick note to reply to, and thx those who took the time to read my ranting post today. Indeed, it seems we are all pretty much aligned.
Appreciate all of those who replied!
Let's goooo!!!
10BagR